BACKGROUND: Although colorectal cancer (CRC) mortality rates are declining, racial-ethnic disparities in CRC mortality nationally are widening. Herein, the authors attempted to identify county-level variations in this pattern, and to characterize counties with improving disparity trends. METHODS: The authors examined 20-year trends in US county-level black-white disparities in CRC ageadjusted mortality rates during the study period between 1989 and 2010. Using a mixed linear model, counties were grouped into mutually exclusive patterns of black-white racial disparity trends in age-adjusted CRC mortality across 20 three-year rolling average data points. County-level characteristics from census data and from the Area Health Resources File were normalized and entered into a principal component analysis. Multinomial logistic regression models were used to test the relation between these factors (clusters of related contextual variables) and the disparity trend pattern group for each county. RESULTS: Counties were grouped into 4 disparity trend pattern groups: 1) persistent disparity (parallel black and white trend lines); 2) diverging (widening disparity); 3) sustained equality; and 4) converging (moving from disparate outcomes toward equality). The initial principal component analysis clustered the 82 independent variables into a smaller number of components, 6 of which explained 47% of the county-level variation in disparity trend patterns. CONCLUSIONS: County-level variation in social determinants, health care workforce, and health systems all were found to contribute to variations in cancer mortality disparity trend patterns from 1990 through 2010. Counties sustaining equality over time or moving from disparities to equality in cancer mortality suggest that disparities are not inevitable, and provide hope that more communities can achieve optimal and equitable cancer outcomes for all. Cancer 2016;122:1735-48.
INTRODUCTION
Colorectal cancer (CRC) is the third most common cancer and the third leading cause of cancer death in the United States, 1 and is expected to account for >8% of US cancer deaths in men and women in 2015, although death rates are on the decline. [1] [2] [3] [4] On average, since 1990 there has been an annual average percentage decrease in CRC mortality of 2.6% for men and 3.0% for women. 5 Unfortunately, the benefits of decreasing mortality have not accrued equally to all segments of the population. Indeed, the racial (black-white) gap in CRC mortality has been increasing since the 1990s. 6, 7 Black or African American individuals have higher CRC mortality rates than whites, with sex-specific black mortality rates from 2007 to 2011 of 28.4 (male) and 18.9 (female) per 100,000 individuals, compared with white rates of 18.7 and 13.2 per 100,000 men and women, respectively. 1, 2 As with other conditions for which lifesaving innovations have emerged, 8 these racial disparities appear to have accelerated since the 1970s, during the very time when more effective screening, early detection, and treatment combined to increase overall 5-year survival rates. Screening and treatment disparities occur along racial-ethnic lines, as well as across states and by insurance status. 9 From 1975 to 1977, the difference in 5-year survival rates was only 6% (51% for white individuals and 45% for black individuals), but by 2004 to 2010 had increased to 11% (5-year survival rate of 67% for white individuals and 56% for black individuals). 5, 10 In short, the blackwhite CRC mortality gap is widening.
Nevertheless, racial differences in mortality trends are not the same in every geographic community. There is demonstrable county-level variation in overall population mortality, 11 mortality among young and middle-aged black men, 12 human immunodeficiency virus mortality, 13 infant mortality, 14 and breast cancer mortality. 15 With respect to breast cancer, we previously demonstrated that although one-half of counties in the United States with sufficient numbers to generate stable mortality rates have shown persistent black-white inequality (parallel black and white mortality trend lines), approximately one-fourth of counties demonstrated diverging trend lines (increasing disparities). 16 Of greatest interest, we have identified counties that have either sustained equality of black and white mortality over the past 20 years or have moved from a past history of high disparities to a current state of near equality (converging trend lines). These counties demonstrate that disparities and the pattern of widening disparities during an overall mortality decline are not inevitable, and suggest that there may be characteristics of communities succeeding on a path toward equality of cancer outcomes even in the face of persistent poverty.
The purpose of the current study was to analyze county-level black-white disparity trends in CRC mortality over 2 decades, first to confirm that there were counties demonstrating each of these 4 disparity trend patterns in their progress toward more equitable CRC outcomes: 1) sustained equality (overlapping trend lines); 2) persistent (parallel) inequality; 3) worsening disparities (diverging trend lines); and 4) progress toward equality (converging trend lines). Next, we sought factors or groups of variables that could profile these communities in terms of trends in their health care infrastructure and the socioeconomics of the population. Our ultimate goal through these observational and hypothesis-generating studies will be to understand what makes "successful" or "positive deviance" communities different, and then to learn whether understanding these characteristics could provide a path to greater equality for communities currently stuck in highdisparity patterns.
MATERIALS AND METHODS

Data
The initial sample included 3141 US counties and county equivalents. We compiled county-level data from 2 sources, including county-level mortality rates from the Centers for Disease Control and Prevention's (CDC) Compressed Mortality File (CMF) through a data use agreement with the National Center for Health Statistics, 17 and county- We examined county-level black-white disparities in CRC age-adjusted mortality rates per 100,000 individuals aged 35 to 74 years during the study period between 1989 and 2010. We adjusted the mortality rates using age distributions of the US population for each year , which allowed us to compare the rates over time and reduce the potential for confounding by age.
Some counties had small population sizes and reported relatively few CRC deaths during the study period. For 1999 to 2013, 94.8% of black or African American individuals resided within the top 830 counties. 19 We selected counties with at least 11 annual CRC deaths per year to protect confidentiality. To adjust for instability of rates from small areas, we used 3-year rolling averages as a smoothing technique, which (combined with the inclusion criteria) assured that all data points would represent rates calculated from at least 20 deaths, which is the CDC criterion for stable mortality rates. For example, the ageadjusted 3-year average mortality rate for 2000 is the average of 3 years of data in that county (eg, mortality rates from 1999, 2000, and 2001). Thus 22 years of annual rates from 1989 to 2010 generated 20 three-year rolling average data points (each 3-year rolling average data point centered on a specific year, from 1990 through 2009). Our final sample included 698 counties from 43 states.
Dependent Variable: Racial Disparity Trend Patterns
We grouped each county into 1 of the following 4 mutually exclusive patterns of black-white racial disparity trends in age-adjusted CRC mortality: 1) persistent disparities (mortality trends were perhaps improving, but black-white trend lines were parallel; gap remained unchanged); 2) sustained equality (black and white mortality were essentially equal and trend lines were overlapping throughout the study period); 3) converging toward equality; and 4) diverging toward greater disparities (increasing black-white gap).
To achieve this simple 4-pattern categorization, we allowed only 1 trend line for each county for the entire 20-year period, rather than allowing for various up-and-down trend lines and myriad trend patterns that would result from multispline or joinpoint analysis. We accomplished this grouping of counties in the following manner. We first calculated the ratio of black-white age-adjusted mortality rates, and used a mixed linear model to estimate the disparity trends across 20 three-year rolling average data points at the county level, by setting the black-white mortality rate ratio as the outcome and time as an independent variable. The estimation method was specified as the maximum likelihood. Among alternative covariance structures for the mixed linear models, we used the unstructured covariance matrix so that we would not impose any constraints on the values. We defined a "converging toward equality" trend pattern as one in which the slope of the black-white mortality rate ratio over time was significantly less than zero (P<.05). Counties with a slope of the black-white CRC mortality rate ratio over time that was significantly greater than zero (P<.05) were defined as diverging (increasing disparities gap). For each remaining county (eg, those with for which the black-white mortality rate ratio was not changing [slope was not significantly different from zero over time]), we used a Student t test for paired data to separate those with persistent inequality from those with sustained equality.
Independent Variables for Principal Component Analysis
The AHRF has 6626 variables on each county in the United States, covering variables including the health care professional workforce, hospitals and health care facilities, census data, socioeconomic indicators, and environmental measures. A total of 82 variables related to health personnel, health facilities, social determinants, and demographic population profiles were considered to be potentially relevant to CRC diagnosis, treatment, and survival. To make the diverse scaling of each of those variables more comparable in factor analysis, a feature scaling normalization was used to transform the measured variables into a range from 0 to 1. Feature scaling can be expressed as x 0 5
X2X min X max 2X min , in which X represents the measured variable and X 0 represents the feature-scaled variable.
PROC FACTOR Analyses
We entered these normalized variables into a principal component analysis (PCA), 20 using the PROC FACTOR procedure 21, 22 with the varimax rotation option in SAS statistical software (SAS Institute Inc, Cary, NC). 23 This approach allowed us to reduce a larger set of potentially correlated variables to a smaller set of variables (principal components).
Based on a scree plot of diminishing impact eigenvalues, we selected the 6 principal components (factors) that accounted for nearly one-half (45.7%) of the variability in the data. We used PROC FACTOR in SAS statistical software (SAS Institute Inc) to identify nearly collinear sets of variables. The 47 variables reflected in these 6 factors are shown in Table 1 . We then selected specific variables from each set of highly correlated variables by choosing the variables with the highest component weighting. In this way, we selected a set of largely uncorrelated variables for each factor to examine in a multivariable setting, while we retained the inherent representation of the underlying analyses.
Interpreting the Rotated Solution
Factor loadings indicate the correlations between the observed variables and the larger component (also referred to as the factor or latent variable) that is the conceptual representation of multiple measured variables. Variables with loadings 0.40 were retained. 24 Factors with loadings <0.40 on all factors, or loadings 0.40 on multiple factors, were eliminated. This procedure was repeated until none of the variables had high loading on >1 component. 25 Factor scores are linear composites of the optimally weighted observed variables. Optimal regression weights were multiplied by variable values for each county to create weighted measures, and the products were then summed to obtain each final factor score.
Multinomial Logistic Regression Analyses
Multinomial logistic regression models were used to test the relation between these components or factors (clusters of related contextual variables) and the disparity trend pattern group for each county, using counties with persistent inequality as the comparison (reference) group. Univariate and multivariate models were used to estimate the relationship between factor scores and different disparity patterns. Unadjusted odds ratios (ORs) were obtained for convergent, divergent, and sustained equality groups of counties versus the persistent inequality reference group through multinomial logistic regression, with each factor entered as a single independent variable. The multivariate multinomial logistic regression model was repeated with adjustment for all 6 factors and rural/urban status of the county. ORs with related 95% CIs were reported for each factor score and rural/urban status. We set the level of statistical significance at .05 and all tests were 2-tailed. All analyses and data manipulation were performed with SAS statistical software (version 9.2; SAS Institute Inc). Figure 1 maps the distribution of US counties in each of the 4 disparity trend pattern groups for CRC mortality. Large blank portions of the map reflect that these counties are not precisely representative of all counties in the United States, but rather have been selected in such a way that total population size as well as racial subgroup (black and white) population size had to be sufficiently large to generate stable CRC mortality rates for each subgroup. As a result, counties excluded from the current analysis may be smaller in population size, more likely to be rural or to have lower population density, and less racially diverse on a black-white axis. The majority of counties (423 of 698 counties; 60.6%) demonstrated persistent or even worsening (151 of 698 counties; 21.6%) disparities in CRC mortality. Less than 5% of counties (30 counties) achieved and sustained black-white equality in CRC mortality for the entire 20-year period, but >12% (94 of 698 counties) moved from significant disparities to equality of outcomes.
RESULTS
Comparing this study with our previous breast cancer study, and using the same data resources and same approach to categorizing counties, we found that 45% of counties in the 2 studies had the same disparity trend patterns for both breast cancer and CRC. If we consider convergent and persistent equality as the 2 preferred disparities outcomes (both having reached racial equality in CRC mortality), the matched rate would be as high as 80%. Some counties (Osceola County in Florida and El Paso County in Colorado) achieved both optimal and equitable outcomes in breast cancer as well as in CRC. Rockland County in New York State demonstrated a sustained equality pattern for both CRC and breast cancer disparities. Essex County in Massachusetts, which had shown a converging pattern from disparities to equality in breast cancer outcomes, demonstrated a 20-year sustained equality pattern for CRC. Conversely, in the current study, there were some counties that demonstrated opposing patterns for the 2 sites of cancer (breast and CRC). For example, Hartford County in Connecticut demonstrated a converging pattern of eliminating disparities in breast cancer mortality, but a diverging pattern of increasing racial disparities in CRC.
The initial PCA clustered the 82 independent variables into a smaller number of principal components, which also may be referred to as factors when referring to the factor loadings of each variable. Table 1 describes the percentage of variation in categorical outcomes explained by these components. Twelve components or clusters of variables explained 60% of variance, and 25 components were required to explain 80%. We focused the remainder of our analyses on the 6 components that explained nearly 50% of the variance. We also ran the data using group LASSO (least absolute shrinkage and selection operator) regression. Although the models came out with a slightly different number of factors (8 clusters of variables vs 6 in our analysis), similar variables were clustering together, and the model overall was not significantly better at explaining variation as measured by Akaike information criterion values.
Factor loadings from the principal components analysis are presented in Table 1 . Six factors were selected from all input variables: 1) factor 1: health care workforce A (note also factor 5); 2) factor 2: health care use; 3) factor 3: demographic and socioeconomic status; 4) factor 4: agerelated factors (health care workers and population composition); 5) factor 5: health care workforce B (note also factor 1); and 6) factor 6: health care trends over time.
Regression Analysis
The second stage of analysis after PCA was the multinomial regression analysis of the weighted factors as independent predictors of the disparity trend pattern category for each county. Counties having persistent inequality (parallel but disparate black-white trend lines) were categorized as the reference group, whereas converging, diverging, and sustained equality (overlapping trend lines) were the other 3 values for this categorical outcome variable.
Regression results are presented in Table 2 . The strongest association was noted between the social determinants component (demographic and socioeconomic variables clustered in factor 3) with counties demonstrating a trend of sustained equality, even controlling for other factors (adjusted OR, 2.79; 95% CI, 1.88-4.14). Factor 2 (health care use patterns and a few health care workforce variables) along with the second of 2 health care workforce variable clusters (factor 5) were 2 components found to be associated with counties having a 
DISCUSSION
Cancer Disparity Trends
We have demonstrated that health disparities are not inevitable, and that preexisting racial disparities in CRC mortality can be overcome. These analyses also demonstrated that simplistic answers such as "looking upstream" at social determinants or poverty do not entirely explain the heterogeneity of disparity trend patterns across counties. Instead, we found that although socioeconomic variables were most strongly associated with counties sustaining black-white equality in CRC mortality rates over a 20-year period, there were quite different factors (health care workforce and 20-year trends in health care capacity) associated with counties moving from high disparities to equality of outcomes (converging-pattern counties). The diverging pattern of worsening disparities over time also was more often associated with health care factors than with demographic or socioeconomic factors. This suggests that health care systems (writ large) have substantial power to mitigate (or to exacerbate) the impact of poverty and other social determinants on cancer disparities. Although CRC mortality rates are declining nationwide, they have become disproportionately higher in the poorest counties of the United States among all sex and racial-ethnic subgroups. This represents a reversal of previous patterns of lower CRC mortality in the poorest counties, which were observed as recently as 1992. 26 The results of the current study demonstrate that the trend lines for black and white cancer mortality vary significantly by county and can be grouped into 4 categories: 1) persistent disparities; 2) sustained equality; 3) converging toward equality; and 4) diverging toward greater disparities. These are the same 4 trend patterns we identified in a previous study of county-level variation in breast cancer mortality disparities, 16 and many (but not all) of the counties that had optimal and equitable outcomes in the breast cancer mortality study demonstrated similarly good outcomes in the current study.
Mortality rates for CRC are known to vary both by community characteristics and by individual demographics. Late stage at diagnosis and decreased survival also are associated with race (African American), sex (men), and socioeconomic status (low income). 27 In Georgia (both rural Georgia and Atlanta cancer registries), African Americans had a 40% increased odds of late stage of disease at the time of diagnosis of colon cancer and a 50% decreased odds of undergoing surgery for CRC, with an 11% increased risk of death from colon cancer. 28 African American individuals in Georgia had higher mortality-to-incidence ratios for every type of cancer, with some variation tied to clinical care and social economic factors at the public health district level. 29 Across the nation, rural-urban differences are mixed.
Explaining Heterogeneity in Cancer Trends Across Various Communities
The geographic variation in cancer mortality trends also has been reported in other national studies. For example, although CRC mortality rates have decreased significantly nationwide, there is substantial statewide variation. The decreases in death rates from 1990 to 2007 range from 9% in Alabama to >33% in Massachusetts, Rhode Island, New York, and Alaska, whereas there was no significant decrease noted in Mississippi or Wyoming. 30 There are myriad potential explanatory factors or "determinants" that contribute to poor outcomes in minority and/or low-income patient populations compared with socially advantaged demographic subgroups. Poverty itself (including community resource deficits and strengths), individual stressors, allostatic load, and resiliency factors, as well as a lack of access to or effective use of preventive lifestyle modifications, screening measures, and unequal diffusion of new treatment innovations may all contribute to compromised outcomes. Other potential contributing factors include both biological and social determinants, health literacy, health behaviors, and clinical comorbidities as well as health care coverage, access, and quality. 31 Our study identified specific characteristics of the population, socioeconomic status, health care infrastructure, and health care workforce that were associated with this variation in mortality trend patterns (6 factors or clusters of variables explaining 46% of the variation, and 24 factors explaining 80%).
Socioeconomic Factors as Drivers of County-Level Variation in Racial Disparities in Cancer Outcomes
Social determinant variables were found to be most strongly associated with the trend pattern experienced by <5% of counties (eg, those that have actually achieved and maintained equality of CRC outcomes over the past 20 years compared with the reference group of counties with persistent disparities). This reinforces a large body of research that links local area variation in disparities to socioeconomic factors, including poverty at the individual and neighborhood levels. [32] [33] [34] Residential segregation, neighborhood deprivation, and community resiliency all may influence health outcomes.
Place matters. 35, 36 Advantaged segments of the population tend to be better educated, have higher income, reside in healthier neighborhoods, and have improved access to screening and better quality treatment. 8, 37 One scholar phrased it this way -"Your zip code is a better predictor of your health than your genetic code." 38 Levine et al have even shown mortality rates from seemingly unrelated conditions such as assault, lung cancer, and infant mortality can cluster together as one socially mediated factor, detectable in population data but not individual data. 39 CRC mortality across the United States is associated with neighborhood-level socioeconomic deprivation. 40 In Texas, late detection of cancer was associated with the Well-Being Index of socioeconomic deprivation, as well as lack of health insurance, physician shortage, and Hispanic ethnicity. 41 In a national study, individuals with the least education were found to have significantly higher CRC death rates for each racial ethnic group in virtually all states. Nationwide, one-half of the premature deaths related to CRC could have been prevented if all patients experienced the lowest death rates of the most educated whites. Approximately 60% to 70% of CRC deaths could be averted in Southern states simply by eliminating this education-related disparity. 42 
Health Care Factors: CRC Screening
Just as place matters with regard to social determinants as drivers of racial-ethnic cancer disparities, health care also matters. CRC screening rates vary dramatically from one community to another. Nationally, 1 in 3 adults has not been screened. 43 A spatial multilevel regression analysis by Mobley et al demonstrated that neighborhood-level poverty was the most consistent predictor of county-level endoscopic CRC screening rates. 44 Using Medicare and Medicaid claims data, Wheeler et al demonstrated that community-level risks for not receiving CRC screening included distance to endoscopy, county-level endoscopy rates, and other community-level demographic and socioeconomic factors. 45 Fewer than 50% of eligible individuals had evidence of CRC screening, with even lower rates noted among men, African American individuals, and those covered by Medicaid.
Racial differences in CRC screening rates are not the same in every community. For example, black-white differences in the percentage of the population that is "up-todate" for screening were found to be greatest in Georgia and San Francisco (10% to 16% rate differences), but there were no significant black-white differences noted in Connecticut; Seattle, Washington; or Iowa. 46 CRC screening practices vary across counties due to variations in individual-level and community-level behaviors and insurance coverage, as well as the distribution of health care resources and access to culturally relevant and affordable health care in the community. 47 In 2004, the percentage of adults aged 50 years who were current with CRC screening ranged from 63% in Rhode Island to 42% in Mississippi, with even lower rates observed in the elderly. 9 Black or African American patients may have a higher perception of risk of interventions, and may be less likely to be screened or referred for CRC screening by their physicians. 48 Geospatial methods can identify clusters or hotspots at risk of a late-stage diagnosis of CRC. 49 In the current study, compared with the counties with persistent disparities (persistently unequal, parallel trend lines over 20-year study period), counties with converging patterns demonstrated a positive association with stronger or increasing "health care workforce" and "health care facility" factors. Multilevel analysis of California data by Shariff-Marco et al found that both individual-level socioeconomic status and county-level health professional shortages were associated with decreased CRC screening. 50 Once again, individual-level and county-level factors overlap. For example, both mental health conditions (eg, depression in women) and chronic medical conditions (eg, cardiovascular disease in men) were associated with a lower likelihood of CRC screening in primary care clinics in 2 rural Oregon counties. 51 National Health Interview Survey data also indicated that African American individuals (especially men) are less likely to have been screened for colon cancer compared with all other race-sex groups. 52 The delayed detection of CRC is associated with both physician shortage areas, and with the percentage of residents who are uninsured. 53 
Delays in Diagnosis
Even after screening, there appear to be racial-ethnic differences in time to diagnosis and stage of disease at the time of diagnosis. A delay in CRC surgery of >12 weeks is associated with an adjusted hazard ratio (HR) of 2.65 for all-cause mortality. 54 Halpern et al noted that black and Hispanic patients were less likely to receive treatments on time, across several tumor types, and suggested that Original Article such delays may account for suboptimal outcomes in the minorities studied. 55 In a cohort of 12,181 patients with a diagnosis of CRC who were followed between 1995 and 2007, Wassira et al observed a higher incidence of advanced disease in black and Hispanic individuals compared with white patients, as well as higher mortality in the same subgroups. 56 Silber et al matched black and white patients who were diagnosed with colon cancer between 1991 and 2005, and reported an absolute survival difference of 9.9% (P<.001) in 5-year survival rates in favor of white patients. 57 Samuel et al reported similar findings in patients treated in the Veterans Affairs hospital system. In comparison with white patients, black individuals were less likely to be diagnosed at an early curative stage, and had a poorer 3-year survival from their colon cancer diagnosis. 58 The ongoing use of primary care may be an especially important predictor of the likelihood of cancer screening as well as stage at diagnosis. 59 In a retrospective cohort study of older patients diagnosed with CRC between 1994 and 2005 in the Surveillance, Epidemiology, and End Results-Medicare-linked database, Ferrante et al found that patients with 5 to 10 primary care physician visits had a 16% lower CRC mortality (adjusted HR, 0.84; 95% CI, 0.80-0.88) and a 6% lower all-cause mortality (adjusted HR, 0.94; 95% CI, 0.91-0.97) than patients with only 0 to 1 visits. 60 A case-control study by the same authors confirmed these results of lower CRC mortality (adjusted OR, 0.78; 95% CI, 0.75-0.82) and lower all-cause mortality (adjusted OR, 0.79; 95% CI, 0.76-0.82) for patients with 5 to 10 primary care visits versus those with only 0 to 1 visits. 61 
Health Care Factors: Quality and Intensity of Treatment
Even though patients of low socioeconomic status and the uninsured are more likely to be diagnosed at an advanced stage of disease, they are also less likely to have access to advanced technologies, regardless of stage of disease at the time of diagnosis. 62 In Georgia, rates of surgery and chemotherapy for CRC were lower in rural and low socioeconomic census tracts. In fact, the increased risk of death from CRC in rural areas was entirely explained by census tract socioeconomic status indicators. 63 Failure to deliver evidence-based cancer care varies among CRC treatment centers and across patient subgroups throughout the United States. In general, high-volume centers appear to have better outcomes. 64, 65 Several studies point to local area variation in patients receiving treatment of CRC and survival rate. 66, 67 Urban patients have access to a higher density of surgeons, gastroenterologists, and radiation oncologists. 68 In California, neighborhood-level education was found to be a more powerful predictor of use of a National Cancer Institute-designated cancer center than poverty or unemployment rates. 69 Panchal et al have shown both geographic and sociodemographic variation in the receipt of newer oxaliplatin chemotherapy treatment, 70 and have tied this disparity to differences in survival outcomes. 71 High-volume health institutions often have lower case fatality rates and better cancer outcomes, but black, Hispanic, and Asian patients are less likely to receive care or undergo surgery at those hospitals. 72 Schootman et al found that census tract poverty and individual black race increased both the risk of postoperative complications and the risk of death. 73 There also is a disparity in noncancer mortality (especially cardiovascular disease) among cancer survivors, with African American survivors reporting significantly more cardiovascular disease risk factors (except smoking). 74 Patients with more severe comorbidities also are less likely to undergo colonoscopy screening. 75, 76 One very clear source of racial disparity in cancer survival is the differential burden of comorbid chronic medical conditions experienced by African American individuals. In other words, higher all-cause mortality among black or African American patients with cancer may reflect a greater burden of stroke, congestive heart failure, and diabetes, among others, especially before age 75 years. 77 Wu et al found that patients with cancer who had higher ageadjusted comorbidity indices had a nearly 2-fold greater risk of death within 5 years. 78 There also is significant county-level variation in these racial disparities in chronic disease, which could at least partially account for countylevel variation in all-cause mortality disparities among patients with cancer and cancer survivors.
Health Care System Inequities
Whether at a macroscopic health policy level or an operational level, the positioning of health resources, facilities, and health care professionals impacts health care access and quality, which are directly related to cancer screening, timely diagnosis, and effective treatment. 79 For example, being uninsured may lead to a later stage at diagnosis and lower survival. 80 Higher uninsured rates at the county level are associated with higher rates of late-stage diagnosis and mortality, and a lower likelihood of being recommended for cancer surgery. 81 A secret shopper survey of gastroenterologists in Connecticut demonstrated that only a small number of gastroenterology practices actually accepted Medicaid patients. 82 Although hospitals in California serving a high-volume of patients with CRC were found to have lower CRC death rates, minority patients were significantly less likely to use these high-volume hospitals despite a higher likelihood of living nearby. 83 Further research is needed to understand whether this underuse of high-volume cancer centers is tied to current realities (eg, structural barriers, active discrimination, cultural insensitivity, etc) or whether it is tied to historical patterns of discrimination and community mistrust.
Differing Disparity Trends by Cancer Site in the Same Community
Racial disparity trends in mortality rates are not the same for every disease. 84 The fact that some counties achieved a positive trend pattern for resolving racial disparities in breast cancer mortality but not CRC mortality (or vice versa) suggests that, for many counties, social "determinants" were not deterministic. In other words, the same population living in the same local circumstances experienced a different trend in disparities for CRC than for breast cancer. What was different about the path from precancer to cancer, and from screening to diagnosis to treatment, in these communities with different cancer disparity trend lines for breast cancer versus CRC? Further research is needed to identify specific elements of local health care systems and social support structures that drive differences in site-specific cancer screening, diagnosis, and treatment that may be differentially influencing cancer mortality disparities.
It also is possible that sex differences within each racial group might have a greater impact on county-level variation in CRC disparities than breast cancer disparities. In either case, a detailed local analysis of breast versus CRC screening and treatment disparities might reveal specific intervention points for eliminating racial disparities.
Inequalities in the Diffusion of Lifesaving Innovation
Previous studies have shown that the decline in CRC mortality in the United States is due to increasing CRC screening and therapeutic interventions. Phelan and Link have put forward the fundamental cause hypothesis to explain why conditions experiencing significant overall mortality declines due to innovations in diagnosis and treatment also experience an actual increase in health disparities for these very conditions, due to socioeconomically mediated differences in access to or use of the lifesaving advances. 85 This connects the dots between social determinants and systemic health care inequities.
Conditions for which innovations are most rapidly reducing mortality are the very conditions in which racial disparities in outcomes are increasing. 86 Advantaged segments of the population are better able to take advantage of new lifesaving breakthroughs, and thus social and economic resources available to different segments of the population lead to differential uptake of the innovations, and become increasingly important in influencing mortality disparities. 87 Therefore, inequalities in the diffusion of innovations such as colonoscopy screening, surgical intervention, or chemotherapy can exacerbate racial disparities in CRC. For several decades, in the 20th century, the median survival associated with untreated metastatic colon cancer was only approximately 4 months to 6 months, which was extended by only a few weeks with treatment. Best supportive care was a very reasonable alternative. With new treatments approved since 1998, the median survival of patients with stage IV CRC has been extended to well beyond 2 years, but there remains a disproportionately lower survival rate among African American patients. Even newer pharmacologic and immunotherapeutic treatments are currently in the pipeline, but these may exacerbate disparities if such high-cost treatments are less accessible to underserved and minority segments of the population. It also is not clear that these agents will actually impart a similar benefit to minority populations, because the majority of clinical trials include a paucity of minority subjects, especially high-disparity subgroups such as African Americans. Safety issues also are a concern, because there are reports of differential toxicity profiles across racial groups.
Positive Deviance Framework
What intrigues us is exploring how certain communities are outperforming their peer communities in forging a path to health equity. For example, Levine et al have demonstrated that certain US counties have completely eliminated racial disparities in mortality for African American men across all causes, as well as for cause-specific mortality due to ischemic heart disease, accidents, diseases of the liver, chronic lower respiratory diseases, and mental disorders from psychoactive substance use.
12 Why? How? Beyond risk factors and determinants, it is important to focus on individual strengths and community resiliency to understand "positive deviance." For example, African American survivors of CRC reported that support from family and other survivors of cancer as well as their faith communities were all critical to enhancing their disease coping and posttreatment surveillance. 88 In the same
Original Article way, we can frame counties with a pattern of sustained equality or movement from disparities to health equity as "positive-deviance" communities that have somehow overcome all the social determinants and structural inequities that drive most communities to patterns of persistent and pervasive disparities. Nobel Laureate Amartya Sen emphasized the potential of lower mortality rates as a marker of specific communities in which to look for strengths and sources of resiliency in his landmark work documenting the role of women's education in the attainment of relatively good health outcomes despite poverty in underresourced communities of Kerala, India. 89 Focusing on the success stories or positive-deviance communities is essential, because sometimes the road out is not the same as the road in. Looking backward at risk factors and determinants may be less useful than looking forward at the paths to health equity forged by communities we have categorized as either "converging toward equality" or "sustained equality."
Limitations
The current study has significant limitations. Although our 3-year rolling average method reduces random fluctuations and generates a larger sample size for each data point, it does not account for all the potential nonlinearities that might occur in each county over 20 years. We did not have individual person-level death certificates or any linkages to medical records, and therefore we could not control for stage at diagnosis, comorbidity profiles, or other clinical factors. We also did not have individuallevel socioeconomic data such as income, poverty, education, or insurance status, nor did we have any information regarding any of the individual health behaviors or risk factors (smoking, diet, exercise, etc) associated with CRC incidence and morbidity. [90] [91] [92] We also did not control for migration patterns or county-level demographic trends. For example, if welleducated, well-insured African American individuals moved en masse into a county in which they were poorly represented in the past, it could create the appearance of a county that has improving health outcomes rather than the simple in-migration of individuals more likely to have better outcomes. We also were unable to address the possible contribution of Hispanic ethnicity (separate from black-white race) across the study period because such information is only available after 1998 in the CMF. Cancer mortality trends are quite different for Hispanic versus non-Hispanic black subgroups, and Hispanic migration patterns could possibly affect the overall black-white racial trends.
Although biologic and genetic factors could potentially be viewed as drivers of racial disparities in CRC (analogous to the excess of triple-negative receptor status for breast cancer among African American women), 93, 94 they would only explain community-level differences in disparity trends if we could postulate a mechanism for community-level variation (eg, through differential access to effective treatment for biologically or genetically different cancers). We had no data with which to assess genetic or other biologic factors.
Data from the CMF also do not provide any information regarding stage of disease at the time of diagnosis, and therefore we could not control for different diagnosisto-survival periods. If survival times are different, the observed mortality in different counties might reflect different diagnosis periods. In fact, variations in cancer mortality disparities across different counties could reflect variations at various levels: screening, stage at diagnosis, time to first treatment, treatment quality, comorbidities, and social support/survivor care issues. Therefore, we focused on mortality rates to understand first which counties were achieving a measure of success as measured by moving toward racial equality of cancer mortality, and plan further research to understand the mechanisms by which convergence or divergence of racial trend lines may occur.
Finally, we did not have county-level data regarding race-specific access to cancer treatment centers nor to any measures of the quality of care received by individual patients. Nevertheless, the strength of the current study is that it incorporated data from all death certificates for all US counties with sufficient population size and diversity and numbers of deaths to generate stable rates and to demonstrate that cancer outcome disparities are not inevitable. We also were able to identify characteristics of counties that cluster into latent factors that match with some known elements of conceptual or explanatory models of health disparities, such as social determinants and health care infrastructure and workforce. The optimal and equitable outcome counties found in the current study provide hope that more counties and ultimately the entire nation can achieve optimal and equitable cancer outcomes for all.
Conclusions
County-level variation in social determinants, health care workforce, and health systems all appear to contribute to variations in cancer outcome disparity trend patterns from 1990 through 2010. Further understanding of these contributing factors may lead us to potential solutions for eliminating CRC outcome disparities in a wider range of 
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